Please enable JavaScript.
Coggle requires JavaScript to display documents.
TYPE 1 DIABTES MELLITUS - Coggle Diagram
TYPE 1 DIABTES MELLITUS
NEWER TRENDS
GPR-40 AGONISTS
GLUCAGON ANTAGONITS
SGLT-2 INHIBITORS
MICROFLUIDIC DEVICES
ORGAN-ON-A-CHIP (OoC)
BIOMATERIAL ENCAPSULATIONS
TECHNOLOGICAL ADVANCEMENTS
INSULIN PUMPS
HYBRID CLOSED LOOP SYSYTEMS
CONTINOUS GLUCOSE MONITORING
SMART INSULIN PENS
NOVEL THERAPIES
NANOTECHNOLOGY
NANOCARRIER BASED INSULIN BIOSENSORS
NANO POWERED T1DM THERAPY
SMART NANOPARTICLES
TRANSDERMAL DRUG DELIVERY SYSTEM
REGENARATIVE MEDICINE
GENE THERAPY
ENZYME THERAPY
MICROBIOME MODULATION
ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING
PSYCHOLOGICAL SUPPORT
MENTAL HEALTH SUPPORT
DIABETES EDUCATION
EMERGING THERAPIES
PANCREATIC ISLET TRANSPLANTATION
PANCREATIC TRANSPLANTATION
STEM CELL THERAPY
PHARMACOTHERAPY
INSULIN THERAPY
ADJUNCTIVE THERAPY
LIFESTYLE MODIFICATIONS
PHYSICAL ACTIVITY
STRESS AND SLEEP MANAGEMENT
DIETARY MODIFICATIONS
IMMUNOLOGICAL APPROACHES
MONOCLONAL ANTIBODIES
PEPTIDE VACCINES AND TOLEROGENIC VACCINES
IMMUNOMODULATIONS
CYTOKINE MODULATIONS